CLINICAL_TRIALS
other
· 2024-10-10
Clinical Trial Update: Segmentectomy for Solid-dominant Lung Cancer [Phase 3]
Summary
A Phase 3 clinical trial sponsored by Fudan University evaluating segmentectomy for solid-dominant lung cancer (lung adenocarcinoma) is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Fudan University | Conditions: Segmentectomy, Lung Adenocarcinoma | Phase 3 | Status: RECRUITING